½ÃÀ庸°í¼­
»óǰÄÚµå
1782175

¼¼°èÀÇ °ø±âÁß °¨¿° °ü¸® ½ÃÀå : À¯Çü, ÆÇ¸Å ¼­ºñ½º, ÃÖÁ¾»ç¿ëÀÚ, À¯Åë ä³Îº°(-2032³â)

Global Infection Control in Air Market Research Report by Type, by Sales Service, by End-User, and by Distribution Channel Forecast till 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Market Research Future | ÆäÀÌÁö Á¤º¸: ¿µ¹® 141 Pages | ¹è¼Û¾È³» : Áï½Ã¹è¼Û

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è °ø±â Áß °¨¿° ¹æÁö ½ÃÀå ±Ô¸ð´Â 9.14%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î 2032³â¿¡´Â 126¾ï 5,200¸¸ ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

°ø±â Áß °¨¿° °ü¸®´Â ½Ç³» °ø±â¸¦ ±ú²ýÇÏ°Ô À¯ÁöÇϰí À¯ÇØÇÑ ¹ÚÅ׸®¾Æ, ¹ÙÀÌ·¯½º, ±âŸ °ø±â Áß °¨¿° º´¿øÃ¼¸¦ Á¦°ÅÇÏ´Â °úÁ¤ÀÔ´Ï´Ù. ÀÌ´Â HEPA ÇÊÅÍ, Àڿܼ±, ûÁ¤ °ø±â È帧 ½Ã½ºÅÛ µîÀÇ µµ±¸¸¦ »ç¿ëÇÏ¿© ÀÌ·ç¾îÁý´Ï´Ù. ±× ¸ñÀûÀº °ø±â¸¦ ÅëÇØ °¨¿°ÀÌ È®»êµÉ À§ÇèÀ» ³·Ãß±â À§ÇÔÀÔ´Ï´Ù.

°øÁߺ¸°Ç°ú À§»ý¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó Àü ¼¼°è °ø±â Áß °¨¿° ¹æÁö ½ÃÀåÀº ²ÙÁØÈ÷ ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ÆÒµ¥¹Í°ú °°Àº ¿©·¯ Â÷·ÊÀÇ ¼¼°è °Ç°­ À§±â¸¦ °ÞÀ¸¸é¼­ Á¤ºÎ¿Í °¢Á¾ ±â°üÀº °¨¿° ¿¹¹æÀÇ ÀÏȯÀ¸·Î °ø±â ÁúÀ» Áß¿äÇÏ°Ô ¿©±â°Ô µÇ¾ú½À´Ï´Ù. Äڷγª19, µ¶°¨, °áÇÙ µî °ø±â °¨¿°¼º ÁúȯÀÌ ÁÖ¸ñ¹ÞÀ¸¸é¼­ °íµµÀÇ °ø±â ¿©°ú ±â¼úÀÇ Çʿ伺ÀÌ ºÎ°¢µÇ°í ÀÖ½À´Ï´Ù. ±¸Ã¼ÀûÀ¸·Î HEPA ÇÊÅÍ, UV »ì±Õ, À̿ ±â¹Ý °ø±âûÁ¤ ½Ã½ºÅÛ µîÀÇ ¼Ö·ç¼ÇÀÌ ÀÇ·á±â°üÀ» ºñ·ÔÇØ ³Î¸® µµÀԵǰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Çб³, ±³Åë±â°ü, ÁÖ°Å¿ë °Ç¹° µî ÀÏ¹Ý ½Ã¼³¿¡µµ µµÀÔÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀåÀº ÇöÀç ±ÔÁ¦ Áö¿ø, ¿¬±¸ ÀÚ±Ý ÅõÀÔ, ¸ÂÃãÇü ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ¼öÇý¸¦ ¹Þ°í ÀÖ½À´Ï´Ù.

ÇÑÆí, ³ôÀº ¼³ºñ ºñ¿ë°ú ¿ÀÁ¸ ¹èÃâ¿¡ ´ëÇÑ ¿ì·Á µîÀÌ Æ¯Á¤ Áö¿ª¿¡¼­´Â µµÀÔ À庮À¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ±×·³¿¡µµ ºÒ±¸ÇÏ°í ½ÃÀå¿¡¼­´Â º¸´Ù ¾ÈÀüÇÏ°í º¹ÇÕÀûÀÎ ±â¼úÀ» Á¢¸ñÇÑ Á¦Ç° °³¹ßÀÌ ÁøÇàµÇ°í ÀÖÀ¸¸ç, ±â¼ú Çõ½ÅÀÌ ¼ºÀåÀÇ ¿­¼è°¡ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¼Ò¸Å¾÷, È£ÅÚ, »ç¹«½Ç µî ºñÀÇ·á ºÐ¾ß¿¡µµ ¾ÆÁ÷ Ȱ¿ëµÇÁö ¾ÊÀº Å« »ç¾÷ ±âȸ°¡ ÀÖ½À´Ï´Ù. Àü ¼¼°èÀûÀ¸·Î ½Ç³»°ø±âÁú¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ÀÌ ½ÃÀåÀº À§»ý ¹× ¾ÈÀü °ü·Ã ºÐ¾ß Áß Æ¯È÷ ȸº¹·ÂÀÌ ³ôÀº ºÐ¾ß·Î Æò°¡¹Þ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â ¾ÕÀ¸·Î ´õ¿í °­È­µÉ °ÍÀ̸ç, º¸´Ù ½º¸¶Æ®ÇÏ°í ¾ÈÀüÇϸç À¯¿¬ÇÏ°Ô ÀûÀÀÇÒ ¼ö ÀÖ´Â °ø±â Á¦¾î ½Ã½ºÅÛÀ¸·Î ½ÃÀåÀÌ ÁøÈ­ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

Áö¿ª ºÐ¼®

ºÏ¹Ì¿¡¼­´Â °ø±â Áß °¨¿° ¹æÁö ½Ã½ºÅÛÀÌ ÀÇ·á±â°ü°ú °ø°ø ÀÎÇÁ¶ó Àü¹Ý¿¡ ³Î¸® µµÀԵǰí ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀº ¾ÈÀü, Áö¼Ó°¡´É¼º, È¿À²¼º¿¡ ÁßÁ¡À» µÐ Çõ½Å°ú ±ÔÁ¦ Áؼö ºÐ¾ß¿¡¼­ ¼¼°è¸¦ ¼±µµÇϰí ÀÖ½À´Ï´Ù. µµÀÔÀº ÀÇ·á ÇöÀå»Ó¸¸ ¾Æ´Ï¶ó Çб³, »ç¹«½Ç, ÁÖÅà °ÇÃà¿¡µµ È®»êµÇ°í ÀÖÀ¸¸ç, ¼ÒºñÀÚÀÇ ÀÎ½Ä °³¼±°ú Àû±ØÀûÀÎ Á¤Ã¥ ¼ö¸³ÀÌ ¿¬°èµÇ¾î ½ÃÀåÀÇ ¾ÈÁ¤Àû ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

À¯·´ ½ÃÀå¿¡¼­´Â Àú¹èÃâ ¹× Ä£È¯°æ ±â¼ú µµÀÔ¿¡ ÁßÁ¡À» µÎ°í ÀÖÀ¸¸ç, À̸¦ °ø±âûÁ¤ Àü·«¿¡ ¹Ý¿µÇϱâ À§ÇÑ ³ë·ÂÀÌ ÁøÇàµÇ°í ÀÖ½À´Ï´Ù. °¨¿° ´ëÃ¥Àº ÀÇ·á Á¤Ã¥ ¹× °ÇÃà ¾ÈÀü ±âÁØÀÇ ÇÙ½É ¿ä¼Ò·Î ÀÚ¸® Àâ°í ÀÖÀ¸¸ç, ¿©·¯ ¿©°ú ¹× Á¦±Õ ±â¼úÀ» °áÇÕÇÑ ÇÏÀ̺긮µåÇü ½Ã½ºÅÛ »ç¿ëÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, EU °¢±¹ÀÇ °øµ¿¿¬±¸¿Í ÀÚ±ÝÁö¿øÀÌ ÀÌ ºÐ¾ßÀÇ ±â¼ú Çõ½ÅÀ» °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀº »ê¾÷È­¿Í µµ½Ã»ýȰÀÇ È®ÀåÀ» ¹è°æÀ¸·Î ³ôÀº ¼ºÀåÀÌ ±â´ëµÇ´Â Áö¿ªÀ¸·Î ÁÖ¸ñ¹Þ°í ÀÖ½À´Ï´Ù. °¢±¹ Á¤ºÎ´Â °ø±âÁú °³¼±À» Æ÷ÇÔÇÑ ±¹°¡Àû °Ç°­ ÁõÁø Ä·ÆäÀÎÀ» ÃßÁøÇϰí ÀÖÀ¸¸ç, °¨¿° ´ëÃ¥Àº °ø°ø Á¤Ã¥ÀÇ Áß¿äÇÑ °úÁ¦°¡ µÇ°í ÀÖ½À´Ï´Ù. ¸¹Àº °ø¸³ ¹× »ç¸³ º´¿øµéÀÌ Ã·´Ü ÇÊÅÍ¿Í UV ½Ã½ºÅÛÀ» µµÀÔÇÏ¿© ½Ã¼³À» Çö´ëÈ­Çϰí ÀÖÀ¸¸ç, ±³À°±â°ü°ú °ø°ø½Ã¼³¿¡¼­µµ ÆÒµ¥¹Í ÀÌÈÄ ÀÎÇÁ¶ó °³¼±ÀÇ ÀÏȯÀ¸·Î °ø±â ¾ÈÀü¿¡ ´ëÇÑ ÅõÀÚ°¡ ÁøÇàµÇ°í ÀÖ½À´Ï´Ù.

¼¼°èÀÇ °ø±â Áß °¨¿° ¹æÁö(Airborne Infection Control) ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ½ÃÀå Á¤ÀÇ¿Í °³¿ä, ½ÃÀå ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â °¢Á¾ ¿µÇâ¿äÀÎ ºÐ¼®, ½ÃÀå ±Ô¸ð ÃßÀÌ¿Í ¿¹Ãø, °¢Á¾ ºÎ¹®º°/Áö¿ªº°/ÁÖ¿ä ±¹°¡º° ºÐ¼®, °æÀï ȯ°æ, ÁÖ¿ä ±â¾÷ °³¿ä µîÀÇ Á¤º¸¸¦ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå ¸Å·Â ºÐ¼®

Á¦2Àå ½ÃÀå °³¿ä

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ½ÃÀå ¿ªÇÐ

  • ¼ºÀå ÃËÁø¿äÀÎ
  • ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ±âȸ

Á¦5Àå ½ÃÀå ¿äÀÎ ºÐ¼®

  • °ø±Þ¸Á/¹ë·ùüÀÎ ºÐ¼®
  • Porter¡¯s Five Forces ¸ðµ¨
  • COVID-19 ÆÒµ¥¹ÍÀÇ °ø±âûÁ¤±â ½ÃÀå¿¡ ´ëÇÑ ¿µÇâ

Á¦6Àå ¼¼°èÀÇ °ø±âÁß °¨¿° °ü¸® ½ÃÀå : À¯Çüº°

  • HEPA
  • Ȱ¼ºÅº
  • À̿ ¹× ¿ÀÁ¸ ¹ß»ý±â
  • Àڿܼ±

Á¦7Àå ¼¼°èÀÇ °ø±âÁß °¨¿° °ü¸® ½ÃÀå : ÆÇ¸Å ¼­ºñ½ºº°

  • Åë»ó ÆÇ¸Å
  • ¾ÖÇÁÅÍ ¼­ºñ½º

Á¦8Àå ¼¼°èÀÇ °ø±âÁß °¨¿° °ü¸® ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • »ó¿ë(»ê¾÷¿ë Æ÷ÇÔ)
  • ÁÖÅÿë

Á¦9Àå ¼¼°èÀÇ °ø±âÁß °¨¿° °ü¸® ½ÃÀå : À¯Åë°æ·Îº°

  • ¿ÀÇÁ¶óÀÎ
  • ¿Â¶óÀÎ

Á¦10Àå ¼¼°èÀÇ °ø±âÁß °¨¿° °ü¸® ½ÃÀå : Áö¿ªº°

  • °³¿ä
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ±âŸ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • Çѱ¹
    • È£ÁÖ ¹× ´ºÁú·£µå
    • ±âŸ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • GCC ±¹°¡
    • Æ¢¸£Å°¿¹
    • ºÏ¾ÆÇÁ¸®Ä«
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ³²¹Ì
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ

Á¦11Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®
  • °æÀï ´ë½Ãº¸µå
  • °æÀï ½ÃÀå Æ÷Áö¼Å´×

Á¦12Àå ±â¾÷ °³¿ä

  • MANN+HUMMEL
  • AFPRO
  • AMERICAN AIR FILTER COMPANY, INC
  • AIROCIDE
  • BSH HOME APPLIANCES GROUP
  • DAIKIN
  • HISENSE INTERNATIONAL
  • IQAIR
  • TEKA
LSH 25.08.11

Global Infection Control in Air Market Research Report by Type (Activated Carbon, Ion and Ozone Generator, UV), by Sales Service (Regular, After Sales Service), by End-User (Residential, Commercial), and by Distribution Channel (Offline, Online) Forecast till 2032

Industry Overview

The global infection control in air market is expected to grow to USD 12,652.0 million by 2032, with a notable CAGR of 9.14%. Infection control in air is the process of keeping indoor air clean and free from harmful bacteria, viruses, and other airborne pathogens. This is done by using tools like HEPA filters, UV lights, and clean airflow systems. The goal is to lower the risk of infections spreading through the air.

The global infection control in air market is witnessing steady growth, driven by increased attention to public health and hygiene. After multiple global health emergencies, both governments and institutions have begun to prioritize air quality as part of overall infection prevention. Airborne transmission of diseases such as COVID-19, influenza, and tuberculosis has highlighted the need for advanced air filtration technologies. Solutions like HEPA filters, UV sterilization, and ion-based systems are being installed in healthcare settings and beyond. Educational institutions, transportation hubs, and residential buildings are following the trend. The market is benefiting from regulatory support, research funding, and growing demand for customized systems.

At the same time, restraints like the cost of equipment and concerns about ozone emissions remain a factor in certain areas. Innovation remains central to market progress, with players focusing on safer, multi-technology products. Non-healthcare segments such as retail, hospitality, and offices represent untapped opportunities. Consumer awareness around indoor air quality is rising globally, making this market one of the more resilient ones in the broader hygiene and safety sector. As these trends deepen, the industry is set to evolve with smarter, safer, and more adaptable air control systems.

Industry Segmentations

The global market is classified based on the type, comprising activated carbon, Ion Ozone generators, and UV.

In terms of sales service, the global infection control in air market is segmented into regular and after-sales service.

Online and offline are two types of distribution channels of the global infection control in air market.

Depending on end-users, the global market is divided into residential and commercial.

Regional Analysis

In North America, infection control in air systems are widely implemented across healthcare and public infrastructure. The region continues to lead in innovation and regulatory compliance, with a focus on safety, sustainability, and efficiency. Adoption is strong not only in medical settings but also in schools, offices, and residential buildings. Consumer awareness and proactive policy-making work hand-in-hand to maintain steady market momentum.

European markets are highly focused on integrating low-emission, environmentally conscious technologies into air purification strategies. Infection control measures are a core component of healthcare policies and building safety codes. There is growing use of hybrid systems that combine multiple filtration and sterilization techniques. Collaborative research and funding across EU countries are accelerating innovation in this space.

Asia Pacific stands out as a high-growth region, driven by industrialization and the expansion of urban living. Governments are endorsing national health campaigns that include air quality initiatives, making infection control a public priority. Both public and private hospitals are retrofitting with advanced filtration and UV systems. Educational institutions and public buildings are also investing in air safety as part of post-pandemic infrastructure upgrades.

Infection control in air is gaining traction across the Middle East and Africa as part of broader urban development strategies. From luxury developments to government clinics, air purification is increasingly seen as a must-have. Health ministries in several countries are launching initiatives to improve indoor air in schools and transport hubs. Demand is spreading across income groups due to rising environmental awareness.

South America is gradually aligning its public health goals with improved air quality standards. Infection control in air systems are becoming more common in both public and private healthcare facilities. Efforts are underway to make air purification more accessible through government subsidies and low-cost solutions. The momentum is sustained by a growing interest in healthy living and indoor air hygiene.

Key Players

Major competitors in the global infection control in air market are MANN+HUMMEL, Afpro, Airocide, American Air Filter Company, Inc., BSH Home Appliances Group, Daikin, Hisense International, IQAir, Krug & Priester GmbH & Co. KG, Oxytec, Philips Domestic Appliances Holding B.V., Sharp, Teka, and Xiaomi.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

  • 1.1 MARKET ATTRACTIVENESS ANALYSIS
    • 1.1.1 GLOBAL INFECTION CONTROL IN AIR MARKET, BY TYPE
    • 1.1.2 GLOBAL INFECTION CONTROL IN AIR MARKET, BY SALES SERVICE
    • 1.1.3 GLOBAL INFECTION CONTROL IN AIR MARKET, BY END-USER
    • 1.1.4 GLOBAL INFECTION CONTROL IN AIR MARKET, BY DISTRIBUTION CHANNEL
    • 1.1.5 GLOBAL INFECTION CONTROL IN AIR MARKET, BY REGION

2 MARKET INTRODUCTION

  • 2.1 DEFINITION
  • 2.2 SCOPE OF THE STUDY
  • 2.3 MARKET STRUCTURE
  • 2.4 KEY IMPLEMENTATION CRITERIA

3 RESEARCH METHODOLOGY

4 MARKET DYNAMICS

  • 4.1 INTRODUCTION
  • 4.2 DRIVERS
    • 4.2.1 GROWING AWARENESS OF AIRBORNE INFECTIONS
    • 4.2.2 RISING HEALTHCARE CONCERN
    • 4.2.3 REGULATORY COMPLIANCE
    • 4.2.4 PANDEMIC PREPAREDNESS
    • 4.2.5 SOARING DEMAND FOR HEPA FILTERS IN RESIDENTIAL SETTINGS
  • 4.3 RESTRAINTS
    • 4.3.1 HEALTH CONCERNS WITH OZONE GENERATORS
    • 4.3.2 INITIAL COST AND MAINTENANCE EXPENSES
  • 4.4 OPPORTUNITIES
    • 4.4.1 INCREASING DEMAND IN NON-HEALTHCARE SECTORS
    • 4.4.2 CUSTOMIZED SOLUTIONS FOR SPECIFIC SETTINGS
    • 4.4.3 INTEGRATION OF MULTIPLE TECHNOLOGIES, RAPID URBANIZATION AND INDUSTRIALIZATION

5 MARKET FACTOR ANALYSIS

  • 5.1 SUPPLY/VALUE CHAIN ANALYSIS
    • 5.1.1 RAW MATERIALS AND COMPONENT SUPPLIERS:
    • 5.1.2 MANUFACTURERS:
    • 5.1.3 TECHNOLOGY PROVIDERS:
    • 5.1.4 DISTRIBUTION AND LOGISTICS:
    • 5.1.5 REGULATORY COMPLIANCE AND CERTIFICATION:
    • 5.1.6 END-USERS:
    • 5.1.7 AFTERMARKET SERVICES:
  • 5.2 PORTER FIVE FORCES MODEL
    • 5.2.1 THREAT OF NEW ENTRANTS:
    • 5.2.2 BARGAINING POWER OF BUYERS:
    • 5.2.3 BARGAINING POWER OF SUPPLIERS:
    • 5.2.4 THREAT OF SUBSTITUTE PRODUCTS:
    • 5.2.5 INTENSITY OF COMPETITIVE RIVALRY:
    • 5.2.6 GOVERNMENT AND REGULATORY INFLUENCE:
    • 5.2.7 TECHNOLOGICAL ADVANCEMENTS:
    • 5.2.8 GLOBAL HEALTH CONCERNS:
  • 5.3 IMPACT OF COVID-19 OUTBREAK ON AIR PURIFIER MARKET
    • 5.3.1 IMPACT ON PRODUCTION:
    • 5.3.2 IMPACT ON SUPPLY CHAIN:
    • 5.3.3 IMPACT ON PRICING:
    • 5.3.4 OTHER IMPACTS:

6 GLOBAL INFECTION CONTROL IN AIR MARKET, BY TYPE

  • 6.1 INTRODUCTION
  • 6.2 HEPA
  • 6.3 ACTIVATED CARBON
  • 6.4 ION AND OZONE GENERATOR
  • 6.5 UV

7 GLOBAL INFECTION CONTROL IN AIR MARKET, BY SALES SERVICE

  • 7.1 INTRODUCTION
  • 7.2 REGULAR SALES
  • 7.3 AFTER SALES SERVICE

8 GLOBAL INFECTION CONTROL IN AIR MARKET, BY END-USER

  • 8.1 INTRODUCTION
  • 8.2 COMMERCIAL (INCLUDING INDUSTRIAL)
  • 8.3 RESIDENTIAL

9 GLOBAL INFECTION CONTROL IN AIR MARKET, BY DISTRIBUTION CHANNEL

  • 9.1 INTRODUCTION
  • 9.2 OFFLINE
  • 9.3 ONLINE

10 GLOBAL INFECTION CONTROL IN AIR MARKET, BY REGION

  • 10.1 OVERVIEW
  • 10.2 NORTH AMERICA
    • 10.2.1 U.S
    • 10.2.2 CANADA
    • 10.2.3 MEXICO
  • 10.3 EUROPE
    • 10.3.1 GERMANY
    • 10.3.2 FRANCE
    • 10.3.3 U.K.
    • 10.3.4 ITALY
    • 10.3.5 SPAIN
    • 10.3.6 REST OF EUROPE
  • 10.4 ASIA-PACIFIC
    • 10.4.1 CHINA
    • 10.4.2 JAPAN
    • 10.4.3 INDIA
    • 10.4.4 SOUTH KOREA
    • 10.4.5 AUSTRALIA AND NEW ZEALAND
    • 10.4.6 REST OF ASIA-PACIFIC
  • 10.5 MIDDLE EAST AND AFRICA
    • 10.5.1 GCC
    • 10.5.2 TURKEY
    • 10.5.3 NORTHERN AFRICA
    • 10.5.4 SOUTHERN AFRICA
  • 10.6 SOUTH AMERICA
    • 10.6.1 BRAZIL
    • 10.6.2 ARGENTINA
    • 10.6.3 ROSA

11 COMPETITIVE LANDSCAPE

  • 11.1 MARKET SHARE ANALYSIS
  • 11.2 COMPETITIVE DASHBOARD
  • 11.3 COMPETITIVE MARKET POSITIONING

12 COMPANY PROFILES

  • 12.1 MANN+HUMMEL
    • 12.1.1 COMPANY OVERVIEW
    • 12.1.2 FINANCIAL OVERVIEW
    • 12.1.3 PRODUCTS AND SERVICES
    • 12.1.4 SWOT ANALYSIS
    • 12.1.5 KEY STRATEGIES
  • 12.2 AFPRO
    • 12.2.1 COMPANY OVERVIEW
    • 12.2.2 FINANCIAL OVERVIEW
    • 12.2.3 PRODUCTS AND SERVICES
    • 12.2.4 SWOT ANALYSIS
    • 12.2.5 KEY STRATEGIES
  • 12.3 AMERICAN AIR FILTER COMPANY, INC
    • 12.3.1 COMPANY OVERVIEW
    • 12.3.2 FINANCIAL OVERVIEW
    • 12.3.3 PRODUCTS AND SERVICES
    • 12.3.4 SWOT ANALYSIS
    • 12.3.5 KEY STRATEGIES
  • 12.4 AIROCIDE
    • 12.4.1 COMPANY OVERVIEW
    • 12.4.2 FINANCIAL OVERVIEW
    • 12.4.3 PRODUCTS AND SERVICES
    • 12.4.4 SWOT ANALYSIS
    • 12.4.5 KEY STRATEGIES
  • 12.5 BSH HOME APPLIANCES GROUP
    • 12.5.1 COMPANY OVERVIEW
    • 12.5.2 FINANCIAL OVERVIEW
    • 12.5.3 PRODUCTS AND SERVICES
    • 12.5.4 SWOT ANALYSIS
    • 12.5.5 KEY STRATEGIES
  • 12.6 DAIKIN
    • 12.6.1 COMPANY OVERVIEW
    • 12.6.2 FINANCIAL OVERVIEW
    • 12.6.3 PRODUCTS AND SERVICES
    • 12.6.4 SWOT ANALYSIS
    • 12.6.5 KEY STRATEGIES
  • 12.7 HISENSE INTERNATIONAL
    • 12.7.1 COMPANY OVERVIEW
    • 12.7.2 FINANCIAL OVERVIEW
    • 12.7.3 PRODUCTS AND SERVICES
    • 12.7.4 SWOT ANALYSIS
    • 12.7.5 KEY STRATEGIES
  • 12.8 IQAIR
    • 12.8.1 COMPANY OVERVIEW
    • 12.8.2 FINANCIAL OVERVIEW
    • 12.8.3 PRODUCTS AND SERVICES
    • 12.8.4 SWOT ANALYSIS
    • 12.8.5 KEY STRATEGIES
  • 12.9 TEKA
    • 12.9.1 COMPANY OVERVIEW
    • 12.9.2 FINANCIAL OVERVIEW
    • 12.9.3 PRODUCTS AND SERVICES
    • 12.9.4 SWOT ANALYSIS
    • 12.9.5 KEY STRATEGIES
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦